121 related articles for article (PubMed ID: 28807345)
1. AMPK expression patterns are significantly associated with poor prognosis in breast cancer patients.
Al-Maghrabi J; Al-Sakkaf K; Qureshi IA; Butt NS; Damnhory L; Elshal M; Al-Maghrabi B; Aldahlawi A; Ashoor S; Brown B; Dobson P; Khabaz MN
Ann Diagn Pathol; 2017 Aug; 29():62-67. PubMed ID: 28807345
[TBL] [Abstract][Full Text] [Related]
2. [Cytoplasmic expression of aquaporin-1 in breast cancer cells and its relationship with clinicopathological characteristics and prognosis].
Zhang B; Liu FF; Ma YJ; Gu F
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):904-9. PubMed ID: 24506959
[TBL] [Abstract][Full Text] [Related]
3. Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer.
Bae YK; Kim A; Kim MK; Choi JE; Kang SH; Lee SJ
Hum Pathol; 2013 Oct; 44(10):2028-37. PubMed ID: 23684510
[TBL] [Abstract][Full Text] [Related]
4. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X
Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated AMP-activated protein kinase expression is significantly associated with poor clinical outcomes in bladder carcinoma patients.
Al-Maghrabi J; Qureshi IA; Butt NS; Khabaz MN
Int J Clin Exp Pathol; 2018; 11(7):3718-3725. PubMed ID: 31949755
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between SLP-2 expression and prognosis in laryngeal squamous cell carcinoma and mammary invasive carcinoma].
Cao WF; Zhang LY; Zhang B; Liu MB; Liu ZH; Sun BC
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):332-7. PubMed ID: 20654157
[TBL] [Abstract][Full Text] [Related]
7. Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases.
Shabani N; Mylonas I; Kunert-Keil C; Briese V; Janni W; Gerber B; Friese K; Jeschke U
Anticancer Res; 2005; 25(3A):1761-4. PubMed ID: 16033096
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical staining of leptin is associated with grade, stage, lymph node involvement, recurrence, and hormone receptor phenotypes in breast cancer.
Khabaz MN; Abdelrahman A; Butt N; Damnhory L; Elshal M; Aldahlawi AM; Ashoor S; Al-Maghrabi B; Dobson P; Brown B; Al-Sakkaf K; Al-Qahtani M; Al-Maghrabi J
BMC Womens Health; 2017 Nov; 17(1):105. PubMed ID: 29121911
[TBL] [Abstract][Full Text] [Related]
9. Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome.
Yamashita M; Ogawa T; Zhang X; Hanamura N; Kashikura Y; Takamura M; Yoneda M; Shiraishi T
Breast Cancer; 2012 Apr; 19(2):170-6. PubMed ID: 20978953
[TBL] [Abstract][Full Text] [Related]
10. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
11. Epithelial periostin expression is correlated with poor survival in patients with invasive breast carcinoma.
Kim GE; Lee JS; Park MH; Yoon JH
PLoS One; 2017; 12(11):e0187635. PubMed ID: 29161296
[TBL] [Abstract][Full Text] [Related]
12. COX-2 expression in human breast carcinomas: correlation with clinicopathological features and prognostic molecular markers.
Miglietta A; Toselli M; Ravarino N; Vencia W; Chiecchio A; Bozzo F; Motta M; Torchio B; Bocca C
Expert Opin Ther Targets; 2010 Jul; 14(7):655-64. PubMed ID: 20536410
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
14. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome.
Iwaya K; Ogawa H; Izumi M; Kuroda M; Mukai K
Virchows Arch; 2002 Jun; 440(6):589-93. PubMed ID: 12070597
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
Chen Y; Song J; Jiang Y; Yu C; Ma Z
Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
[TBL] [Abstract][Full Text] [Related]
16. Transglutaminase 2 overexpression in tumor stroma identifies invasive ductal carcinomas of breast at high risk of recurrence.
Assi J; Srivastava G; Matta A; Chang MC; Walfish PG; Ralhan R
PLoS One; 2013; 8(9):e74437. PubMed ID: 24058567
[TBL] [Abstract][Full Text] [Related]
17. Tenascin C is a prognostic determinant and potential cancer-associated fibroblasts marker for breast ductal carcinoma.
Yang Z; Ni W; Cui C; Fang L; Xuan Y
Exp Mol Pathol; 2017 Apr; 102(2):262-267. PubMed ID: 28223108
[TBL] [Abstract][Full Text] [Related]
18. Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer.
Pellikainen J; Kataja V; Ropponen K; Kellokoski J; Pietiläinen T; Böhm J; Eskelinen M; Kosma VM
Clin Cancer Res; 2002 Nov; 8(11):3487-95. PubMed ID: 12429639
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of stromal and epithelial periostin expression in human breast cancer: correlation with clinical pathological features and mortality outcome.
Nuzzo PV; Rubagotti A; Zinoli L; Salvi S; Boccardo S; Boccardo F
BMC Cancer; 2016 Feb; 16():95. PubMed ID: 26872609
[TBL] [Abstract][Full Text] [Related]
20. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
